Trending...
- Yonkers Fire Commissioner Robert Sweeney to Resign from Department
- Thru-hikers Launch New Nature Streaming TV Channel for Nature Lovers
- PRA Health Sciences Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PRA Health Sciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PRAH
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Lizhi Inc. ("Lizhi" or the "Company") (NASDAQ: LIZI) securities American Depositary Shares ("ADSs" or "shares") pursuant and/or traceable to the Company's January 2020 initial public offering ("IPO" of the "Offering"). Investors have until March 22, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
The lawsuit alleges that Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) at the time of the IPO, the coronavirus was already ravaging China, the home base, principal market, and significant hub for Lizhi, its employees, and its customers; (2) the complications associated with the coronavirus were already negatively affecting Lizhi's business, as employees and customers contracted the virus, lost employment, or otherwise experienced difficulty in generating, publishing, and monetizing the content critical to Lizhi's platform; (3) even prior to the IPO, Lizhi employees and customers complained of, and to, Lizhi, which harmed the Company's reputation and financial condition and prospects; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
More on Nyenta.com
On or about January 17, 2020, Lizhi conducted its IPO, issuing 4.1 million ADSs priced at $11.00 per ADS. On April 20, 2020, Lizhi admitted that before the IPO, as early as "late 2019," the COVID-19 pandemic was already negatively impacting its business. Since the IPO, Lizhi shares are currently trading below $4 per share, or more than 60% below the IPO price.
If you purchased or otherwise acquired Lizhi securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website: http://www.kmllp.com.
More on Nyenta.com
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
The lawsuit alleges that Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) at the time of the IPO, the coronavirus was already ravaging China, the home base, principal market, and significant hub for Lizhi, its employees, and its customers; (2) the complications associated with the coronavirus were already negatively affecting Lizhi's business, as employees and customers contracted the virus, lost employment, or otherwise experienced difficulty in generating, publishing, and monetizing the content critical to Lizhi's platform; (3) even prior to the IPO, Lizhi employees and customers complained of, and to, Lizhi, which harmed the Company's reputation and financial condition and prospects; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
More on Nyenta.com
- Registration Opens For The 17th Annual 72 HOUR SHOOTOUT Filmmaking Competition
- Nationally Syndicated Radio Show "Radio Bassment" Launching Daily Programming 7 Days a Week
- Amid Covid's Impact On Women, Companies Join Historic International Women's Day Benefit To Advance Gender Equity, Women In Leadership
- Piedmont Lithium Participates in Range of Virtual Industry Conferences
- Microfiltration Membrane Market Trends, Segment Analysis and Forecast Report by 2030
On or about January 17, 2020, Lizhi conducted its IPO, issuing 4.1 million ADSs priced at $11.00 per ADS. On April 20, 2020, Lizhi admitted that before the IPO, as early as "late 2019," the COVID-19 pandemic was already negatively impacting its business. Since the IPO, Lizhi shares are currently trading below $4 per share, or more than 60% below the IPO price.
If you purchased or otherwise acquired Lizhi securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website: http://www.kmllp.com.
More on Nyenta.com
- Hess to Participate in Credit Suisse Energy Summit
- Breaking Notice: Rosen, a Globally Recognized Law Firm, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – BLUE
- Nano-technology alliance of Supreme Pharmatech and Professor M.R.Mozafari, a global nano technology expert
- AGEAGLE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AgEagle Aerial Systems, Inc. and Encourages Investors to Contact the Firm
- KBRA Assigns Preliminary Ratings to Pagaya AI Debt Selection Trust 2021-1
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Filed Under: Business
0 Comments
Latest on Nyenta.com
- New Voices Foundation to Hold $100,000 Virtual Pitch Competition for Women of Color Entrepreneurs
- Carole Demas, Sarah Rice and Ian Herman Together Again
- Identity Podcast The Importance of Black History
- Pandemic Compliance Services Provides Certified Pandemic Compliance Advisors And Covid-19 Compliance
- Meatless Farm Launches First Plant-Based Hot Dog That Tastes Like a Real Hot Dog
- Sandline Global Fortifies World-Class Executive Team: Glenn Hopper Joins as Chief Financial Officer
- Ponos Industries Extends Tender Offer for up to 1,000,000 Shares of Common Stock of Visa Inc
- GBKSOFT reveals the benefits of Building Websites with PHP in 2021?
- JT Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Jianpu Technology, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
- AdvisorSmith Finds the States Most and Least Uninsured for Health Insurance
- Syxsense Announces Integration with Microsoft Office 365
- Iveric Bio to Present at the Cowen 41st Annual Health Care Conference
- ProStrategix Chosen as #3 Pay per Click Digital Advertising Agency by DesignRush
- Launch of Trace One E-Sourcing Will Boost Retailers' Private Label Speed to Market
- Chlorobenzene Market by Type, Application and Forecast Report by P&S Intelligence
- CTT Portugal Post, Portugal's Postal Operator, Selects Sprinklr to Accelerate its Digital Customer Experience Strategy
- BIN: Black Information Network and The Ad Council Team up With BIN Founding Partners Bank of America, CVS Health, Lowe's, McDonald's USA, Sony, 23andMe and Verizon for "It's Up To You" Vaccine Education Week
- Swati Singh's Debut Novel Available Now for Presale
- Thru-hikers Launch New Nature Streaming TV Channel for Nature Lovers
- AGEAGLE ALERT: Bragar Eagel & Squire, P.C. is Investigating AgEagle Aerial Systems, Inc. on Behalf of AgEagle Stockholders and Encourages Investors to Contact the Firm